Citation: A. Sharma et al., ESTIMATION OF ORAL BIOAVAILABILITY OF A LONG HALF-LIFE DRUG IN HEALTHY-SUBJECTS, Pharmaceutical research, 15(11), 1998, pp. 1782-1786
Authors:
SALAZAR DE
MUCH DR
NICHOLA PS
SEIBOLD JR
SHINDLER D
SLUGG PH
Citation: De. Salazar et al., A PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF D-SOTALOL Q-TC PROLONGATION DURING INTRAVENOUS ADMINISTRATION TO HEALTHY-SUBJECTS, Journal of clinical pharmacology, 37(9), 1997, pp. 799-809
Authors:
GEHR TWB
SICA DA
SLUGG PH
HAMMETT JL
RAYMOND R
FORD NF
Citation: Twb. Gehr et al., THE PHARMACOKINETICS OF PRAVASTATIN IN PATIENTS ON CHRONIC-HEMODIALYSIS, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 117-121
Citation: Dr. Much et al., EFFECTS OF D-SOTALOL AND D,L-SOTALOL ON ISOPROTERENOL-INDUCED INCREASES IN HEART-RATE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 168-168
Citation: Ph. Slugg et al., PHARMACOKINETICS OF D-SOTALOL (DS) AND L-SOTALOL (LS) ADMINISTERED ASDS AND D,L-SOTALOL (DLS), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 168-168
Citation: Ph. Slugg et M. Haug, RANITIDINE PHARMACOKINETICS AND CENTRAL-NERVOUS-SYSTEM - REPLY, Archives of internal medicine, 154(3), 1994, pp. 343-347